Correlation Between Varex Imaging and Enanta Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Varex Imaging and Enanta Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Varex Imaging and Enanta Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Varex Imaging Corp and Enanta Pharmaceuticals, you can compare the effects of market volatilities on Varex Imaging and Enanta Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Varex Imaging with a short position of Enanta Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Varex Imaging and Enanta Pharmaceuticals.

Diversification Opportunities for Varex Imaging and Enanta Pharmaceuticals

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Varex and Enanta is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Varex Imaging Corp and Enanta Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enanta Pharmaceuticals and Varex Imaging is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Varex Imaging Corp are associated (or correlated) with Enanta Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enanta Pharmaceuticals has no effect on the direction of Varex Imaging i.e., Varex Imaging and Enanta Pharmaceuticals go up and down completely randomly.

Pair Corralation between Varex Imaging and Enanta Pharmaceuticals

Given the investment horizon of 90 days Varex Imaging Corp is expected to under-perform the Enanta Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Varex Imaging Corp is 1.82 times less risky than Enanta Pharmaceuticals. The stock trades about -0.1 of its potential returns per unit of risk. The Enanta Pharmaceuticals is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  860.00  in Enanta Pharmaceuticals on November 28, 2024 and sell it today you would lose (11.00) from holding Enanta Pharmaceuticals or give up 1.28% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Varex Imaging Corp  vs.  Enanta Pharmaceuticals

 Performance 
       Timeline  
Varex Imaging Corp 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Varex Imaging Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Enanta Pharmaceuticals 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Enanta Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Enanta Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Varex Imaging and Enanta Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Varex Imaging and Enanta Pharmaceuticals

The main advantage of trading using opposite Varex Imaging and Enanta Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Varex Imaging position performs unexpectedly, Enanta Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enanta Pharmaceuticals will offset losses from the drop in Enanta Pharmaceuticals' long position.
The idea behind Varex Imaging Corp and Enanta Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Bonds Directory
Find actively traded corporate debentures issued by US companies